The Chengdu system for recurrent hepatocellular carcinoma: A step in the right direction

作     者：Simon Erridge Mikael H.Sodergren 

作者机构：Department of Surgery and CancerImperial College LondonLondonUK 

出 版 物：《Hepatobiliary Surgery and Nutrition》 (肝胆外科与营养（英文）)

年 卷 期：2019年第8卷第3期

页      面：298-300页

核心收录：

学科分类：1002[医学-临床医学] 100214[医学-肿瘤学] 10[医学] 

主　　题：Liver Eastern alcohol 

摘      要：Liver cancer is the fourth leading cause of cancer-related death *** carcinoma(HCC),the most prevalent cause of primary liver cancer,is observed highest in the Far East,South-Eastern Asia and East Africa(1).In most endemic regions this is secondary to the prevalence of specific risk factors including chronic hepatitis B virus(HBV)infection,hepatitis C virus(HCV)infection and aflatoxin-exposure(1,2).The development of HBV vaccination and programmes to reduce HBV transmission has reduced the risk of HCC in high-risk Asian countries(1).Global incidence of HCC however continues to rise and major contributory factors to this are alcohol misuse and the obesity epidemic,resulting in non-alcoholic fatty liver disease,in Western nations(1,2).